The Global Uveitis Treatment Market Continues To Grow Owing To the Increasing Prevalence of Uveitis in the World

 

Uveitis Treatment Market

Uveitis Treatment Market, by Treatment Type (Corticosteroids, Immunosuppressant, Monoclonal Antibodies, Cycloplegic Agents, Antibiotics, Antivirals, Antifungal, Analgesics), by Disease type (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Pan uveitis), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030.

Market Overview:

Global Uveitis Treatment Market size is estimated to be valued at US$ 710.0 million in 2022 and is expected to exhibit a CAGR of 5.3% between 2022 and 2030.

Uveitis is an inflammatory condition that affects the uvea, which is the middle layer of the eye that contains blood vessels that supply the retina. The uvea also includes the iris (the colored part of the eye), the ciliary body (which produces the fluid inside the eye), and the choroid (which supplies blood to the retina).

Treatment for uveitis depends on the underlying cause and the severity of the inflammation. It may include the use of topical or oral corticosteroids to reduce inflammation, immunosuppressive drugs to prevent the immune system from attacking the eye, and biological agents that target specific components of the immune system. In severe cases, surgery may be necessary to treat complications such as cataracts or glaucoma that can develop as a result of uveitis.

Competitive Landscape:

Major players operating in the global Uveitis Treatment Market include Santen Pharmaceuticals, EyePoint Pharmaceuticals, Alimera Science Inc., Eyegate Pharmaceuticals, Inc., AbbVie Inc., Bausch Health Inc., Novartis AG, and AbbVie (Allergan), Inc.

Key Market Drivers:

Uveitis is a relatively common inflammatory condition of the eye that affects people of all ages. The increasing prevalence of uveitis, particularly in developing countries, is expected to drive the growth of the global Uveitis Treatment Market. For instance, according to the American Ocular Immunology and Uveitis Foundation, every year around 43,000 new cases of uveitis are diagnosed every year in the United States. Uveitis can cause vision loss and blindness if left untreated, leading to a higher demand for effective treatments.

Biologic drugs, which are derived from living cells and are designed to target specific components of the immune system, have emerged as an effective treatment option for uveitis. The growing demand for biologics is estimated to enhance the growth of the global uveitis treatment market.

Covid-19 Impact Analysis:

During the COVID-19 pandemic, there have been several developments in the global Uveitis Treatment Market. For instance, in December 2020, Alimera Sciences Europe Limited introduced ILUVIEN in the Netherlands.

Key Takeaways:

·       North America is expected to dominate the growth of the global uveitis treatment market. The region's growth is driven by the high prevalence of uveitis, the availability of advanced healthcare facilities, and the high adoption of biologics. For instance, in October 2021, Clearside Biomedical and Bausch + Lomb the United States Food and Drug Administration approved an injectable suspension called XIPERE.

·       The Asia-Pacific region is estimated to witness high growth in the global uveitis treatment market, due to the increasing prevalence of uveitis, the rising geriatric population, and the growing healthcare infrastructure in developing countries. For instance, according to AmbitionBox, there are around 175 biotechnology companies in India currently.

Comments

Post a Comment

Popular posts from this blog

Forging has significant application in creation of various metal for wide range of applications

Image
Forging refers to any process that produces metal from scratch by subjecting it to an external force. Metal forgers can be persons or machines. This techniques may involve grinding (for example, to produce alloyed steel) or may involve the application of pressure to apply heat to the metal piece until it is malleable. The actual process depends on various factors, including the material being forged, its shape, and the degree of stress that is placed on it. Forged grain is the product of Forging with grains of metals pushed against each other through a forge-like tool and into the cladding that forms the final shape of the metal after it has been done. It is the principal production process in most metals. It uses local or repetitive thrusts delivered by a hammer or die to apply mechanical blows to the metal piece until it becomes malleable. It is frequently classified according to the speed at which it's done: fast, cold, or hot. There are many types of forgers available today...
Read more

Ginseng Market Outlook, Analysis and forecast up to 2028

Image
  Ginseng Market Ginseng is a slow-growing perennial plant with green oval-shaped leaves and meaty roots that can persist for more than a century. Ginseng is classified into two types: American ginseng and Asian ginseng. Panax quinquefolius is the scientific name for American ginseng, whereas Panax ginseng is the scientific name for Asian ginseng. Ginseng is widely used as a herb to increase the body's energy levels. Ginseng's antioxidant and anti-inflammatory qualities serve to enhance the immune system, lowering the risk of viral and microbial infections. Ginseng also helps to lower the risk of diseases such as lung cancer, skin cancer, and liver cancer. Other health advantages of ginseng include lower blood sugar levels and improved cognitive functions such as memory and conduct. Ginseng is mostly grown in the United States, Canada, and South Korea. Ginseng has been used as a herbal medicine in China for generations, and the country is one of its largest users. Asia Pacifi...
Read more

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19

Image
Germany Vaccine Contract Manufacturing industry is expected to witness significant growth in the near future, due to emergence of Covid-19. In Germany, from 3 January 2020 to 4:06pm CEST, 18 August 2021, there have been 3,835,375 confirmed cases of COVID-19 with 91,921 deaths, reported to WHO. As of 15 August 2021, a total of 97,884,043 vaccine doses have been administered. The increasing demand for safe and cost-effective vaccines due to unmatchable quality, consistent delivery, and unparalleled security, have contributed to the increasing growth and scope of this industry. The increasing demand for vaccines and resulting profit potential have led to significant growth in the number of contract manufacturing plants located across the world. A major focus of such plants is developing cost effective, high quality vaccines that could be made available to public health organizations and other medical organizations. Several new and innovative technologies are also being developed to man...
Read more